Supernus Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSupernus Pharmaceuticals

Supernus Pharmaceuticals(SUPN)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Oxtellar	Oxcarbazepine	2012-10-19	2027	Epilepsy , Partial epilepsies
Qelbree	Viloxazine	2021-04-02	2029-2033	Depression
Trokendi	Topiramate	2013-08-16	2027-2040	Pain , Epilepsy , Lennox gastaut syndrome , Infantile spasms , Partial epilepsies , Tonic-clonic epilepsy , Bipolar disorder , Obesity
Gocovri	Amantadine	2017-08-24	2025-2038	Parkinson disease, Secondary parkinson disease, Human influenza, Dystonia, Drug-induced dyskinesia, Drug-induced akathisia
Osmolex	Amantadine	2018-02-16	2025-2038	Parkinson disease, Secondary parkinson disease, Human influenza, Dystonia, Drug-induced dyskinesia, Drug-induced akathisia

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

migraine disorders

,

partial epilepsies

,

attention deficit disorder with hyperactivity

,

mucocutaneous lymph node syndrome

,

myeloid leukemia acute

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

angelman syndrome

,

huntington disease

,

developmental disabilities

,

mental disorders

,

neurodevelopmental disorders

,

autistic disorder

,

autism spectrum disorder

,

pervasive child development disorders

,

non-small-cell lung carcinoma

,

,

muscular atrophy

,

spinal muscular atrophy

,

,

multiple myeloma

,

plasma cell neoplasms

,

follicular lymphoma

,

diabetes mellitus

,

non-hodgkin lymphoma

,

alzheimer disease

,

sickle cell anemia

,

,

type 2 diabetes mellitus

,

paroxysmal hemoglobinuria

,

,

,

obsessive-compulsive disorder

,

compulsive personality disorder

,

brain neoplasms

,

unknown primary neoplasms

,

stomach neoplasms

,

small cell lung carcinoma

,

,

breast neoplasms

,

,

colorectal neoplasms

,

,

triple negative breast neoplasms

,

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

multiple sclerosis

,

myeloid leukemia

,

rheumatoid arthritis

,

,

chronic renal insufficiency

,

kidney diseases

,

,

,

bcr-abl positive chronic myelogenous leukemia

,

,

renal cell carcinoma

,

,

,

,

,

,

,

systemic scleroderma

,

diffuse scleroderma

,

,

,

cerebrovascular disorders

,

giant cell arteritis

,

polymyalgia rheumatica

,

mucinous adenocarcinoma

,

ductal carcinoma breast

,

inflammatory breast neoplasms

,

chronic hepatitis

,

,

,

,

,

chronic hepatitis c

,

neoplasm metastasis

,

renal insufficiency

,

chronic kidney failure

,

chronic hepatitis b

,

iron-deficiency anemia

,

lymphatic diseases

,

iron deficiencies

,

hepatocellular carcinoma

,

liver neoplasms

,

,

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

interstitial lung diseases

,

,

,

acquired immunodeficiency syndrome

,

liver cirrhosis

,

spinal muscular atrophies of childhood

,

attention deficit disorder with hyperactivity

,

,

impulsive behavior

,

attention deficit disorder with hyperactivity

,

,

impulsive behavior

parkinson disease

muscle spasticity

,

atrial fibrillation

,

essential tremor

,

,

abdominal hernia

,

,

,

internal hernia

,

migraine disorders

,

,

,

,

non-hodgkin lymphoma

,

,

b-cell chronic lymphocytic leukemia

,

b-cell lymphoma

,

lymphoid leukemia

,

muscular dystrophies

,

,

,

major depressive disorder

,

depressive disorder

,

migraine disorders

,

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use